METHOD AND SYSTEM FOR INDUCING ANTI-AGING IN SKIN WITH A LIGHT AND TOPICAL ADDITIVE
    6.
    发明申请
    METHOD AND SYSTEM FOR INDUCING ANTI-AGING IN SKIN WITH A LIGHT AND TOPICAL ADDITIVE 审中-公开
    用光和局部添加剂诱导皮肤抗老化的方法和系统

    公开(公告)号:WO2009137612A3

    公开(公告)日:2010-02-04

    申请号:PCT/US2009043028

    申请日:2009-05-06

    Inventor: PITCHER STEPHEN

    Abstract: A method of treating the skin and accelerating its natural anti-aging and wound-healing processes by using photorejuvenation at a specified total light flux at a specified range of wavelengths from a hand-held light source in combination with the topical ingredients including extracts. Some extracts may be panax ginseng, camellia sinensis, and/or gynostemma pentaphyllum, to effect superior transdermal penetration and intra-cellular delivery, effecting greater bioavailability and bioutilization of some other anti-aging topicals.

    Abstract translation: 通过使用来自手持光源的特定波长范围内的规定的总光通量与包括提取物的局部成分组合的光老化来加速其天然抗衰老和伤口愈合过程的方法。 一些提取物可以是人参,山茶花和/或绞股蓝五倍子,以实现优异的透皮渗透和细胞内递送,实现更大的生物利用度和一些其它抗衰老外用剂的生物利用。

    COMPOSITION, DELIVERY SYSTEM AND METHOD FOR PROMOTING HEALTHY SEXUAL FUNCTION
    8.
    发明申请
    COMPOSITION, DELIVERY SYSTEM AND METHOD FOR PROMOTING HEALTHY SEXUAL FUNCTION 审中-公开
    组合物,递送系统和促进健康功能的方法

    公开(公告)号:WO2006057893A3

    公开(公告)日:2006-08-24

    申请号:PCT/US2005041765

    申请日:2005-11-17

    Abstract: Improved compositions, delivery systems and methods for promoting healthy sexual function. The compositions include a portion or extract of the plant Sophora flavescens, such as sophoflavescenol. The compositions also include Vitex agnus-castus extract, and/or one or more of lipoic acid, L-Arginine, folic acid, trimethylglycine, policosanol, carnitine, biotin, and acetyl L-Carnitine and anti-oxidants. A composition including one or more cGMP-specific PDE5 inhibitors and/or dopaminergic agonists is administered in the form of a breath-care strip, mint or lozenge, or a food or beverage product. The cGMP-specific PDE5 inhibitor comprises an ingredient selected from the group consisting of sophoflavescenol, vardenafil, tadalafil, and sildenafil. The dopaminergic agonist comprises apomorphine. Vitex agnus-castus extract, and/or one or more of lipoic acid, L-Arginine, folic acid, trimethylglycine, policosanol, carnitine, biotin, and acetyl L-Carnitine may also be included in the delivery vehicle.

    Abstract translation: 改善组合物,递送系统和促进健康性功能的方法。 组合物包括植物苦参(Phora flavescens)的一部分或提取物,例如类胡萝卜素。 组合物还包括Vitex恶心 - 提取物,和/或一种或多种硫辛酸,L-精氨酸,叶酸,三甲基甘氨酸,二十烷醇,肉毒碱,生物素和乙酰基左旋肉碱和抗氧化剂。 包含一种或多种cGMP特异性PDE5抑制剂和/或多巴胺能激动剂的组合物以呼吸保健条,薄荷或锭剂或食品或饮料产品的形式施用。 cGMP特异性PDE5抑制剂包含选自由下列组成的组的成分:类胡萝卜素,伐地那非,他达拉非和西地那非。 多巴胺能激动剂包括阿扑吗啡。 Vitex us us提取物和/或一种或多种硫辛酸,L-精氨酸,叶酸,三甲基甘氨酸,二十烷醇,肉毒碱,生物素和乙酰基L-肉毒碱也可以包括在递送载体中。

    METHOD OF USING GERANIUM OIL AND SOPHORA ROOT EXTRACTS AS A SUPPORTING COMPOSITION IN CANCER TREATMENTS
    10.
    发明申请
    METHOD OF USING GERANIUM OIL AND SOPHORA ROOT EXTRACTS AS A SUPPORTING COMPOSITION IN CANCER TREATMENTS 审中-公开
    使用甘油和罗非鱼提取物作为癌症治疗中的支持组合物的方法

    公开(公告)号:WO2004035075A1

    公开(公告)日:2004-04-29

    申请号:PCT/US2002/033467

    申请日:2002-10-15

    CPC classification number: A61K36/48 A61K36/185 A61K36/489 A61K2300/00

    Abstract: The present invention relates to a method of use involving the administration of the herbal composition, comprising geranium oil and extracts from roots of the plants of the genus Sophora, to mammalian animals undergoing cancer treatments that would induce the bone marrow suppression side effect, such as chemotherapy and radiation therapy. The composition can take on the form of an oil capsule, tablets, pills, and pastes etc. to be administered orally at specific dosages. The composition can also take on the form of an injection to be administered intravenously and intraperitoneally at specific dosages. The administration can be made before and or after the cancer treatment. In one embodiment, the composition is administered intraperitoneally.

    Abstract translation: 本发明涉及一种使用方法,其包括将天竺葵油和从佐布索植物的根的提取物施用于哺乳动物进行癌症治疗的哺乳动物的使用方法,所述哺乳动物将诱导骨髓抑制副作用,例如 化疗和放射治疗。 组合物可以以油胶囊,片剂,丸剂和糊剂等的形式以特定剂量口服给药。 组合物也可以采取注射的形式,以特定剂量静脉内和腹膜内给药。 可以在癌症治疗之前和之后进行给药。 在一个实施方案中,组合物被腹膜内给药。

Patent Agency Ranking